Turmeric compound tested against resistant colon cancer
NCT ID NCT02724202
First seen Feb 06, 2026 · Last updated May 09, 2026 · Updated 10 times
Summary
This early-stage study tested whether adding curcumin (a compound found in turmeric) to standard chemotherapy could help patients with advanced colon cancer that no longer responds to the drug 5FU. The trial enrolled 15 adults with metastatic colon cancer and aimed to check safety and any signs of tumor shrinkage. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor Charles A. Sammons Cancer Center
Dallas, Texas, 75246, United States
Conditions
Explore the condition pages connected to this study.